Kisqali 600 MG daily dose 63S
Ended Awarded
- Contract number
- SPE2DB25FBF82
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $167,318
Award facts
- Contract value 100% obligated
- $167,317.68 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $167,317.68 to AmerisourceBergen Drug Corp for the supply of Kisqali 600 mg daily dose tablets (63-count units) with a completion date of September 29, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and was issued on September 27, 2025. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen serves the Department of Defense healthcare systems through its extensive portfolio of brand-name and generic medications, vaccines, and specialized medical supplies.
This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement running through December 2026 that enables comprehensive global pharmaceutical support for military healthcare programs. The IDC serves as a flexible vehicle for supplying pharmaceutical products and medical commodities to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems worldwide. AmerisourceBergen's consistent selection for federal pharmaceutical procurement reflects its demonstrated capability to meet competitive requirements and deliver diverse medical products across multiple therapeutic domains to support military and veteran healthcare needs.
Quick answers
Who was awarded contract SPE2DB25FBF82?
SPE2DB25FBF82 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 27, 2025.
How much is contract SPE2DB25FBF82 worth?
The government has obligated $167,318 on SPE2DB25FBF82.
Is contract SPE2DB25FBF82 an order under another contract?
Yes. SPE2DB25FBF82 is a delivery order under SPE2DB22D3009, an indefinite delivery contract.
Was contract SPE2DB25FBF82 competed?
The extent of competition for SPE2DB25FBF82 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award